Local News

$40 Million Payment Triggers Bonuses For Pozen Execs, Certain Other Employees

Posted October 2, 2006

— A $40 million payday from drug development partner AstraZeneca means bonuses for some


executives and "certain" non-executive employees.

In a filing with the Securities and Exchange Commission, Pozen (Nasdaq: POZN) disclosed the payment of $535,150 in bonuses based on the AstraZeneca deal to jointly develop a pain reliever.

Kristina Adomonis, senior vice president of business development, gets the biggest bonus: $180,400.

Chief Executive Officer John Plachetka receives $169,950.

Also getting bonuses were Chief Financial Officer William Hodges ($16,500) and Marshall Reese, executive vice president for product development.

Other bonuses will be distributed at Plachetka's discretion, Pozen said.


Please with your WRAL.com account to comment on this story. You also will need a Facebook account to comment.

Oldest First
View all